Taro Granted Tentative Approval For First Lamisil Cream Equivalent
This article was originally published in The Tan Sheet
Executive Summary
Taro Pharmaceuticals has received what appears to be the first tentative approval in the U.S. for a generic version of Novartis' OTC antifungal cream Lamisil, the Israeli firm announced March 23